Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
National Bank of Greece S.A. (NBGPY) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
National Bank of Greece S.A. NBGPY
Board Mod:
Add me as mod
Asst Mods:
Last Post: 01/14/2016 1:03:24 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 1
National Bank of Greece S.A. (OTCMRKTS: NBGPY) Stock Message Board
NBGPY Company Profile
NBGPY Time & Sales
NBGPY Recent News
NBGPY Filings
NBGPY Financials
NBGPY Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
Be the first to post on National Bank of Greece S.A. NBGPY
Recent Articles
Novo Nordisk's Strategic Acquisition of Catalent's Manufacturing Assets
Catalent and Novo Holdings Set to Finalize Major Deal Soon
Opportunity for Wolfspeed Investors to Pursue Class Action
Kyverna Therapeutics Investors Alert Over Recent Class Action
Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
Urgent Alert for Symbotic Investors Regarding Class Action
Investors Reminded of Key Deadline in PACS Group Lawsuits
Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
Important Update for Rentokil Investors on Class Action Lawsuit
Important Update for Match Group Investors: Legal Actions Ahead
Investors Urged to Act in Zeta Global Class Action Case
Celsius Holdings Investors: Important Litigation Updates
ASML Holding Class Action: Important Update for Investors
Deadline Approaches for Hasbro Shareholders in Class Action
Critical Update for Toronto-Dominion Bank Investors in Class Action
Investors of Kyverna Therapeutics Can Pursue Class Action
Xi Jinping Supports Hong Kong's Economic Strategies and Development
Solar Alliance Energy Gains Shareholder Approval in Key Meeting
Fruit Street Health Enhances Diabetes Prevention with Meals
CNOOC Limited Partners with INEOS Energy in New Agreement
Exciting Collaboration: Celebrate Japan's Fruit Culture
Investors Urged to Act Before Deadline in Xiao-I Class Action
Karma Sauce Applauds First We Feast's Bold New Direction
Cassava Sciences Investors Encouraged to Act on Stock Losses
Investors Warned of Upcoming Deadline in WM Technology Case
Investors Urged to Act: Acadia Healthcare Class Action Deadline
Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
Legal Action Announced for Five9, Inc. Investors Following Stock Decline
Legal Action Launched for Kyverna Therapeutics Investors
Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
Haloid Enhances Safety in Film Productions with Reviews
Insights on the Growing Demand for Edible Coatings in Produce
Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
Legal Update: Toronto-Dominion Bank Securities Class Action
Key Updates from Nasdaq on the Nasdaq-100 Index Changes
TeraBox Revolutionizes File Sharing with Free Unlimited Service
Kessler Topaz Takes Action Against Enphase Energy for Fraud
Demesne Resources Completes Second Tranche of Financing
Spiro Celebrated as One of the Top Agencies in Marketing
Global Uranium Corp. Launches Strategic Marketing Efforts
UnitedHealth Group Clarifies Misconceptions and Updates Claims
Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
Acadia Healthcare Investors Urged to Take Action on Lawsuit
Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
Hola Prime's Innovative Vision: New Marketing Director Appointed
Teamsters Advocate for Stronger Standards on Autonomous Vehicles
BioVaxys Secures Funding and Enters Debt Settlement Agreement
Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment